Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL1B | P01584 | 12/20 | 0.51 |
| ▸ | NLRP3 | Q96P20 | 10/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
| ▸ | TNF | P01375 | 2/20 | 0.42 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.41 |
| ▸ | CCNK | O75909 | 2/20 | 0.41 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.41 |
| ▸ | CDK2 | P24941 | 2/20 | 0.41 |
| ▸ | CDK9 | P50750 | 2/20 | 0.41 |
| ▸ | CDK12 | Q9NYV4 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25798433 | 0.87 | NLRP3 (0.60) | IL1BNLRP3KCNH2TNF | |
| SCHEMBL25798977 | 0.87 | IL1B (0.66) | IL1BNLRP3 | |
| SCHEMBL30665784 | 0.84 | CCNK (0.50) | IL1BNLRP3KCNH2TNFCCNT1 | |
| SCHEMBL30665785 | 0.84 | CCNK (0.50) | IL1BNLRP3KCNH2TNFCCNT1 | |
| SCHEMBL25797696 | 0.82 | IL1B (0.60) | IL1BNLRP3KCNH2TNF | |
| SCHEMBL29270337 | 0.81 | IL1B (0.53) | IL1BNLRP3KCNH2TNF | |
| SCHEMBL25798979 | 0.80 | IL1B (0.54) | IL1BNLRP3KCNH2TNFCCNT1 | |
| SCHEMBL25798381 | 0.80 | NLRP3 (0.57) | IL1BNLRP3KCNH2TNF | |
| SCHEMBL25797801 | 0.78 | IL1B (0.75) | IL1BNLRP3 | |
| SCHEMBL25798127 | 0.78 | IL1B (0.75) | IL1BNLRP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023129987-A1 | PYRIDAZINE DERIVATIVES AS MODULATORS OF NLRP3 INFLAMMASOME AND RELATED METHODS | Neumora Therapeutics, Inc. (US) | 2023-07-06 | — | — | WO | disclosed |